Filing Flows › Kestra Medical Technologies (KMTS) › Q1 FY27
Kestra Medical Technologies (KMTS) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Sep 14, 2026
Kestra Medical Technologies (KMTS) reported revenue of $31.0M for the first quarter fiscal 2027 (Q1 FY27), +60% from a year earlier and +8% from the quarter before. Operating margin was -121.6%, net loss $44.1M (142.3% of revenue).
Kestra Medical Technologies, Q1 FY27: revenue $31.0M (+60% year over year), operating margin -121.6%, net loss $44.1M, operating cash flow −$32.3M. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.0M | +8% | +60% |
| Operating profit | −$37.7M | — | — |
| Net earnings | −$44.1M | — | — |
| Operating cash flow | −$32.3M | — | — |
What changed
Revenue was $31.0M in Q1 FY27, up 60% year over year and up 8% from the previous quarter.
Gross margin was 56.5%, up 10.8 points from Q1 FY26. Operating costs exceeded revenue by $37.7M, an operating margin of -121.6%. Operating expenses grew 46% against revenue growth of 60%. The fastest-growing cost line was Research & development (+70%). The quarter ended with a net loss of $44.1M, wider than the previous quarter's $38.8M loss.
Operating cash flow was −$32.3M. Non-cash charges added back $2.7M of depreciation and $9.5M of share-based compensation. Capital expenditures of $8.3M exceeded it, leaving free cash flow of −$40.6M.
Questions
What was Kestra Medical Technologies' revenue in the first quarter fiscal 2027?
Kestra Medical Technologies (KMTS) reported revenue of $31.0M for the first quarter fiscal 2027 (Q1 FY27), +60% from a year earlier and +8% from the quarter before.
Was Kestra Medical Technologies profitable in the first quarter fiscal 2027?
Operating loss was $37.7M (-121.6% of revenue) and net loss $44.1M.